Quarterly report pursuant to Section 13 or 15(d)

FAIR VALUE MEASUREMENT (Tables)

v3.21.2
FAIR VALUE MEASUREMENT (Tables)
9 Months Ended
Jun. 30, 2021
Fair Value Disclosures [Abstract]  
The following table sets forth by level within the fair value hierarchy the Company’s derivative financial instruments that were accounted for at fair value on a recurring basis as of September 30, 2020, and June 30, 2021, respectively:

The following table sets forth by level within the fair value hierarchy the Company’s derivative financial instruments that were accounted for at fair value on a recurring basis as of September 30, 2020, and June 30, 2021, respectively:

 

                         

Description

 

Quoted Prices in

 Active Markets

for

Identical Assets
(Level 1)
 

 

 

Significant

Other

Observable

Inputs
(Level 2)

 

 

Significant Other

Unobservable

Inputs

(Level 3)

 

 

Total Fair
Value as of

 

Derivative Financial Instrument at September 30, 2020

 

$

 

 

 

$

(1,070,551

)

 

$

 

 

 

$

(1,070,551

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivative Financial Instrument at June 30, 2021

 

$

 

 

$

(1,332,229

)

 

$

 

 

$

(1,332,229

)

 

The change in derivative financial instruments for the nine months ended June 30, 2021 is as follows:

The change in derivative financial instruments for the nine months ended June 30, 2021 is as follows:

 

September 30, 2020 balance

 

$

(1,070,551)

 

New derivative instruments issued

 

 

 

Derivative instruments extinguished

 

 

46,261

 

Change in fair value

 

 

(307,939)

 

June 30, 2021 balance

 

$

(1,332,229)